Our mission is to develop innovative nanoparticle-based technologies to enhance the delivery of therapeutics and diagnostics.
Many valuable drugs do not possess the appropriate chemical and/or physical properties to be efficiently formulated and delivered to sites of disease.
Integrated Nanotherapeutics Inc. is a biopharmaceutical company focused on the development of novel drugs and diagnostics in the areas of cancer and autoimmunity, including diabetes, where there is significant unmet medical need for therapeutic and diagnostic agents with improved activity.
Our proprietary technologies allow the incorporation of any compound in lipid nanoparticle delivery systems and thus extend the benefits of delivery systems to virtually any therapeutic and diagnostic agent. We envision that many existing drugs or agents can be made much safer and more effective using our technologies.